Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2014

01-01-2014 | Original Article

Exome Sequencing Revealed Novel Germline Mutations in Chinese Peutz–Jeghers Syndrome Patients

Authors: Huan-Huan Wang, Na-Na Xie, Qi-Yuan Li, Yi-Qun Hu, Jian-Lin Ren, Bayasi Guleng

Published in: Digestive Diseases and Sciences | Issue 1/2014

Login to get access

Abstract

Background and Aims

Peutz–Jeghers Syndrome (PJS) is an autosomal dominant disorder which predisposes to the development of various cancers. Germline mutation in the serine/threonine kinase 11 gene (STK11) is known as one of the major causes of PJS. However, a notable proportion of PJS samples do not carry any mutation in STK11, suggesting possible genetic heterogeneity in the disease and the existence of other causative variants.

Methods and Results

In order to identify other germline variants in the coding regions of the genome that are associated with PJS, we performed exome sequencing in three Chinese individuals with PJS and identified 16 common germline variants (12 protein-coding including STK11, 4 in pre-microRNAs). We further validated protein-coding variants in six PJS individuals (three with wild-type STK11) and predicted the functional impact. As result, we found that 7 coding variants are likely to have functional impacts. Especially, we identified 2 new germline variants which are represented in all six PJS samples and are independent of STK11 mutation.

Conclusions

Our study provided an exomic view of PJS. The germline variants identified in our analysis may help to resolve the complex genetic background of the disease and thus lead to the discovery of novel causative variants of PJS.
Appendix
Available only for authorised users
Literature
2.
go back to reference Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am. 2002;31:1107–1131.PubMedCrossRef Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am. 2002;31:1107–1131.PubMedCrossRef
3.
go back to reference Perzin KH, Fenoglio CM, Pascal RR. Tumors of the small and large intestine. Princ Pract Surg Pathol. 1983; 899–936. Perzin KH, Fenoglio CM, Pascal RR. Tumors of the small and large intestine. Princ Pract Surg Pathol. 1983; 899–936.
4.
go back to reference Jeghers H, Mc KV, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits: a syndrome of diagnostic significance. N Engl J Med. 1949, 241:993 (illust; passim). Jeghers H, Mc KV, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits: a syndrome of diagnostic significance. N Engl J Med. 1949, 241:993 (illust; passim).
6.
go back to reference Tovar JA, Eizaguirre I, Albert A, Jimenez J. Peutz–Jeghers syndrome in children: report of two cases and review of the literature. J Pediatr Surg. 1983;18:1–6.PubMedCrossRef Tovar JA, Eizaguirre I, Albert A, Jimenez J. Peutz–Jeghers syndrome in children: report of two cases and review of the literature. J Pediatr Surg. 1983;18:1–6.PubMedCrossRef
7.
go back to reference Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol. 2005;100:476–490.PubMedCrossRef Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol. 2005;100:476–490.PubMedCrossRef
8.
go back to reference Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology. 2000;119:1447–1453.PubMedCrossRef Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology. 2000;119:1447–1453.PubMedCrossRef
9.
go back to reference Boardman LA, Thibodeau SN, Schaid DJ, et al. Increased risk for cancer in patients with the Peutz–Jeghers syndrome. Ann Intern Med. 1998;128:896–899.PubMedCrossRef Boardman LA, Thibodeau SN, Schaid DJ, et al. Increased risk for cancer in patients with the Peutz–Jeghers syndrome. Ann Intern Med. 1998;128:896–899.PubMedCrossRef
10.
go back to reference Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med. 1987;316:1511–1514.PubMedCrossRef Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med. 1987;316:1511–1514.PubMedCrossRef
11.
go back to reference van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME: High cancer risk in Peutz–Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 2010; 105:1258–1264 (author reply 1265). van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME: High cancer risk in Peutz–Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 2010; 105:1258–1264 (author reply 1265).
12.
go back to reference Mehenni H, Blouin JL, Radhakrishna U, et al. Peutz–Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am J Hum Genet. 1997;61:1327–1334.PubMedCentralPubMedCrossRef Mehenni H, Blouin JL, Radhakrishna U, et al. Peutz–Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am J Hum Genet. 1997;61:1327–1334.PubMedCentralPubMedCrossRef
13.
go back to reference Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome. Nature. 1998;391:184–187.PubMedCrossRef Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome. Nature. 1998;391:184–187.PubMedCrossRef
14.
go back to reference Westerman AM, Entius MM, Boor PP, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz–Jeghers families. Hum Mutat. 1999;13:476–481.PubMedCrossRef Westerman AM, Entius MM, Boor PP, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz–Jeghers families. Hum Mutat. 1999;13:476–481.PubMedCrossRef
15.
go back to reference Davidson NO. Genetic testing in colorectal cancer: who, when, how and why. Keio J Med. 2007; 56:14–20. Davidson NO. Genetic testing in colorectal cancer: who, when, how and why. Keio J Med. 2007; 56:14–20.
16.
go back to reference Jenne DE, Reimann H, Nezu J, et al. Peutz–Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18:38–43.PubMedCrossRef Jenne DE, Reimann H, Nezu J, et al. Peutz–Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18:38–43.PubMedCrossRef
17.
go back to reference de Leng WW, Jansen M, Carvalho R, et al. Genetic defects underlying Peutz–Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet. 2007;72:568–573.PubMedCentralPubMedCrossRef de Leng WW, Jansen M, Carvalho R, et al. Genetic defects underlying Peutz–Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet. 2007;72:568–573.PubMedCentralPubMedCrossRef
18.
go back to reference Katajisto P, Vaahtomeri K, Ekman N, et al. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat Genet. 2008;40:455–459.PubMedCrossRef Katajisto P, Vaahtomeri K, Ekman N, et al. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat Genet. 2008;40:455–459.PubMedCrossRef
19.
go back to reference McGarrity JT, Amos C. Peutz–Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci. 2006;63:2135–2144.PubMedCrossRef McGarrity JT, Amos C. Peutz–Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci. 2006;63:2135–2144.PubMedCrossRef
20.
go back to reference Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M. The mTOR pathway and its role in human genetic diseases. Mutat Res. 2008;659:284–292.PubMedCrossRef Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M. The mTOR pathway and its role in human genetic diseases. Mutat Res. 2008;659:284–292.PubMedCrossRef
21.
go back to reference Westerman AM, Entius MM, Boor PP, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz–Jeghers families. Hum Mutat. 1999;13:476–481.PubMedCrossRef Westerman AM, Entius MM, Boor PP, et al. Novel mutations in the LKB1/STK11 gene in Dutch Peutz–Jeghers families. Hum Mutat. 1999;13:476–481.PubMedCrossRef
22.
go back to reference Bali D, Gourley IS, McGarrity TJ, Spencer CA, Howard L, Frazier ML, Lynch PM, Seldin MF, Amos CI: Peutz–Jeghers syndrome maps to chromosome 1p. Am J Hum Genet. 1995;57 (suppl.):A186 Bali D, Gourley IS, McGarrity TJ, Spencer CA, Howard L, Frazier ML, Lynch PM, Seldin MF, Amos CI: Peutz–Jeghers syndrome maps to chromosome 1p. Am J Hum Genet. 1995;57 (suppl.):A186
23.
go back to reference Markie D, Huson S, Maher E, Davies A, Tomlinson I, Bodmer WF. A pericentric inversion of chromosome six in a patient with Peutz–Jeghers’ syndrome and the use of FISH to localise the breakpoints on a genetic map. Hum Genet, 1996;98:125–128. Markie D, Huson S, Maher E, Davies A, Tomlinson I, Bodmer WF. A pericentric inversion of chromosome six in a patient with Peutz–Jeghers’ syndrome and the use of FISH to localise the breakpoints on a genetic map. Hum Genet, 1996;98:125–128.
24.
go back to reference Alhopuro P, Phichith D, Tuupanen S, et al. Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad Sci U S A. 2008;105:5513–5518.PubMedCentralPubMedCrossRef Alhopuro P, Phichith D, Tuupanen S, et al. Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad Sci U S A. 2008;105:5513–5518.PubMedCentralPubMedCrossRef
25.
go back to reference Boardman LA, Couch FJ, Burgart LJ, et al. Genetic heterogeneity in Peutz–Jeghers syndrome. Hum Mutat. 2000;16:23–30.PubMedCrossRef Boardman LA, Couch FJ, Burgart LJ, et al. Genetic heterogeneity in Peutz–Jeghers syndrome. Hum Mutat. 2000;16:23–30.PubMedCrossRef
26.
go back to reference Schumacher V, Vogel T, Leube B, et al. STK11 genotyping and cancer risk in Peutz–Jeghers syndrome. J Med Genet. 2005;42:428–435.PubMedCrossRef Schumacher V, Vogel T, Leube B, et al. STK11 genotyping and cancer risk in Peutz–Jeghers syndrome. J Med Genet. 2005;42:428–435.PubMedCrossRef
27.
29.
go back to reference Jones S, Wang TL, Shih IM et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330:228–231. Jones S, Wang TL, Shih IM et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330:228–231.
30.
go back to reference Li H, Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 2009; 25:1754–1760. Li H, Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 2009; 25:1754–1760.
31.
go back to reference Li H, Handsaker B, Wysoker A, et al. The sequence alignment/map (SAM) format and SAMtools. Bioinformatics. 2009;25:2078–2079.PubMedCrossRef Li H, Handsaker B, Wysoker A, et al. The sequence alignment/map (SAM) format and SAMtools. Bioinformatics. 2009;25:2078–2079.PubMedCrossRef
32.
33.
go back to reference Li R, Zhu H, Ruan J, et al. De novo assembly of human genomes with massively parallel short read sequencing. Genome Res. 2010;20:265–272.PubMedCrossRef Li R, Zhu H, Ruan J, et al. De novo assembly of human genomes with massively parallel short read sequencing. Genome Res. 2010;20:265–272.PubMedCrossRef
34.
go back to reference Altshuler D, Durbin RM, Abecasis GR, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–1073.PubMedCrossRef Altshuler D, Durbin RM, Abecasis GR, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–1073.PubMedCrossRef
35.
go back to reference Faircloth BC, McCormack JE, Crawford NG, Harvey MG, Brumfield RT, Glenn TC. Ultraconserved elements anchor thousands of genetic markers spanning multiple evolutionary timescales. Syst Biol. 2012; 59:307–321 Faircloth BC, McCormack JE, Crawford NG, Harvey MG, Brumfield RT, Glenn TC. Ultraconserved elements anchor thousands of genetic markers spanning multiple evolutionary timescales. Syst Biol. 2012; 59:307–321
36.
go back to reference Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Prot. 2009;4: 1073–1081. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Prot. 2009;4: 1073–1081.
38.
go back to reference Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43:309–315.PubMedCrossRef Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43:309–315.PubMedCrossRef
39.
40.
go back to reference Ausavarat S. Novel mutations in theSTK11gene in Thai patients with Peutz–Jeghers syndrome. World J Gastroenterol. 2009;15:5364.PubMedCrossRef Ausavarat S. Novel mutations in theSTK11gene in Thai patients with Peutz–Jeghers syndrome. World J Gastroenterol. 2009;15:5364.PubMedCrossRef
41.
go back to reference Braun T, Voland P, Kunz L, Prinz C, Gratzl M. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology. 2007;132:1890–1901.PubMedCrossRef Braun T, Voland P, Kunz L, Prinz C, Gratzl M. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology. 2007;132:1890–1901.PubMedCrossRef
42.
go back to reference Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Gastrointest Liver Physiol. 2008;295:G260–G272.PubMedCrossRef Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Gastrointest Liver Physiol. 2008;295:G260–G272.PubMedCrossRef
43.
go back to reference Kaji I, Karaki S, Kuwahara A. Effects of luminal thymol on epithelial transport in human and rat colon. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1132–G1143.PubMedCrossRef Kaji I, Karaki S, Kuwahara A. Effects of luminal thymol on epithelial transport in human and rat colon. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1132–G1143.PubMedCrossRef
44.
go back to reference Bi M, Hickox JR, Winfrey VP, Olson GE, Hardy DM. Processing, localization and binding activity of zonadhesin suggest a function in sperm adhesion to the zona pellucida during exocytosis of the acrosome. Biochem J. 2003;375:477–488.PubMedCrossRef Bi M, Hickox JR, Winfrey VP, Olson GE, Hardy DM. Processing, localization and binding activity of zonadhesin suggest a function in sperm adhesion to the zona pellucida during exocytosis of the acrosome. Biochem J. 2003;375:477–488.PubMedCrossRef
45.
go back to reference Yanagisawa H, Miyashita T, Nakano Y, Yamamoto D. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ. 2003;10:798–807.PubMedCrossRef Yanagisawa H, Miyashita T, Nakano Y, Yamamoto D. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ. 2003;10:798–807.PubMedCrossRef
46.
go back to reference Karuman P, Gozani O, Odze RD, et al. The Peutz–Jegher (sic) gene product LKB1 is a mediator of p53-dependent cell death. Molec Cell 2001;7:1307–1319. Karuman P, Gozani O, Odze RD, et al. The Peutz–Jegher (sic) gene product LKB1 is a mediator of p53-dependent cell death. Molec Cell 2001;7:1307–1319.
47.
go back to reference Shadan A, Khaldoun A, Wei C, Philip A, Sarkar FH. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res. 2011;3:28–47. Shadan A, Khaldoun A, Wei C, Philip A, Sarkar FH. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res. 2011;3:28–47.
48.
go back to reference Canto MI. Screening and surveillance approaches in familial pancreatic cancer. Gastrointest Endosc Clin N Am. 2008; 18:535–553. Canto MI. Screening and surveillance approaches in familial pancreatic cancer. Gastrointest Endosc Clin N Am. 2008; 18:535–553.
49.
go back to reference Greenhalf W, Malats N, Nilsson M, Bartsch D, Neoptolemos J. International registries of families at high risk of pancreatic cancer. Pancreatology. 2008;8:558–565.PubMedCrossRef Greenhalf W, Malats N, Nilsson M, Bartsch D, Neoptolemos J. International registries of families at high risk of pancreatic cancer. Pancreatology. 2008;8:558–565.PubMedCrossRef
Metadata
Title
Exome Sequencing Revealed Novel Germline Mutations in Chinese Peutz–Jeghers Syndrome Patients
Authors
Huan-Huan Wang
Na-Na Xie
Qi-Yuan Li
Yi-Qun Hu
Jian-Lin Ren
Bayasi Guleng
Publication date
01-01-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2875-7

Other articles of this Issue 1/2014

Digestive Diseases and Sciences 1/2014 Go to the issue

Stanford Multidisciplinary Seminars

An Elusive Cause of Severe Gastrointestinal Bleeding

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.